JARID2 and urinary bladder carcinoma: To examine whether Jarid2 is critical for the tumorigenicity of bladder cancer TICs in vivo, we performed limiting dilutions (100, 500, 2500, 1 × 104 and 1 × 105) of ALDHhigh cell sorted from stable Jarid2-sh 5637 and SCaBER cells.